Yang K D, Bathras J M, Shigeoka A O, James J, Pincus S H, Hill H R
Department of Pediatrics, University of Utah School of Medicine, Salt Lake City 84132.
J Infect Dis. 1989 Apr;159(4):701-7. doi: 10.1093/infdis/159.4.701.
To study the mechanism of bacterial opsonization by immune globulin intravenous (IGIV) complement consumption and polymorphonuclear leukocyte (PMNL) membrane receptor (FcRlo, CR1, and CR3)-mediated phagocytosis of Staphylococcus epidermidis, Klebsiella pneumoniae, and groups A and B streptococci were examined. IGIV alone did not consume complement and showed no opsonic activity by itself for these organisms. When these bacteria were preopsonized in IGIV, significant amounts of complement were consumed (44%-94%) and the uptake and killing of bacteria occurred. The in vitro opsonic activity of IGIV for these organisms was significantly correlated with the amount of complement consumed by the IGIV-opsonized bacteria (r = .85, P less than .05). The in vivo protective efficacy of IGIV also appeared to be directly associated with its ability to activate and consume complement (r = 1.0, P less than .001). Antibodies to FcRlo (Leu 11) markedly inhibited phagocytosis of bacteria opsonized in IGIV but not that of bacteria opsonized in specific IgM. Both CR1 and CR3 receptors on PMNLs were involved in uptake, but the contribution of each is different with different organisms.
为研究静脉注射免疫球蛋白(IGIV)补体消耗以及多形核白细胞(PMNL)膜受体(FcRlo、CR1和CR3)介导的对表皮葡萄球菌、肺炎克雷伯菌以及A组和B组链球菌的吞噬作用在细菌调理作用中的机制,对这些细菌进行了检测。单独的IGIV不会消耗补体,且自身对这些微生物没有调理活性。当这些细菌在IGIV中进行预调理时,会消耗大量补体(44% - 94%),并且会发生细菌的摄取和杀伤。IGIV对这些微生物的体外调理活性与IGIV调理的细菌消耗的补体量显著相关(r = 0.85,P < 0.05)。IGIV的体内保护功效似乎也与其激活和消耗补体的能力直接相关(r = 1.0,P < 0.001)。针对FcRlo(Leu 11)的抗体显著抑制了在IGIV中调理的细菌的吞噬作用,但不抑制在特异性IgM中调理的细菌的吞噬作用。PMNL上的CR1和CR3受体都参与摄取,但每种受体对不同微生物的作用不同。